Novo’s Wegovy successor disappoints in second large trial
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
How a Copenhagen housing project by a $23 billion Novo-backed firm is rethinking big-city challenges like loneliness and access to sunlight
If you want to address civilization and society's issues, then you have to do it with the city," Urban Partners' co-CEO Claus ...
Fierce Pharma3d
With blood and growth disorder bids panning out, Novo Nordisk plots path to rare disease leadership: exec
Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...